Latest news with #ShreeGaneshRemedies
Business Standard
20-05-2025
- Business
- Business Standard
Shree Ganesh Remedies consolidated net profit declines 47.66% in the March 2025 quarter
Sales decline 34.56% to Rs 24.43 crore Net profit of Shree Ganesh Remedies declined 47.66% to Rs 6.59 crore in the quarter ended March 2025 as against Rs 12.59 crore during the previous quarter ended March 2024. Sales declined 34.56% to Rs 24.43 crore in the quarter ended March 2025 as against Rs 37.33 crore during the previous quarter ended March 2024. For the full year,net profit declined 17.93% to Rs 23.07 crore in the year ended March 2025 as against Rs 28.11 crore during the previous year ended March 2024. Sales declined 13.74% to Rs 108.60 crore in the year ended March 2025 as against Rs 125.90 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 24.4337.33 -35 108.60125.90 -14 OPM % 40.4045.38 - 36.1033.21 - PBDT 11.2018.11 -38 40.8344.27 -8 PBT 8.7716.25 -46 31.2738.16 -18 NP 6.5912.59 -48 23.0728.11 -18
Business Upturn
20-05-2025
- Business
- Business Upturn
Shree Ganesh Remedies shares tumble over 8% after Q4 net profit drops 48% YoY
By Aditya Bhagchandani Published on May 20, 2025, 10:17 IST Shares of Shree Ganesh Remedies Ltd declined sharply by 8.17% on Tuesday, trading at ₹716 on the BSE, down from the previous close of ₹779.70. The steep fall comes in response to weak Q4 FY25 earnings. For the quarter ended March 2025, the company's net profit slumped 47.66% year-on-year to ₹6.59 crore, compared to ₹12.59 crore in the corresponding period last year. Revenue from operations also saw a major decline of 34.56%, falling to ₹24.43 crore from ₹37.33 crore. The company's operating profit margin (OPM) also contracted to 40.40% from 45.38% in the year-ago quarter, further reflecting margin pressures. For the full fiscal year, net profit declined 17.93% to ₹23.07 crore from ₹28.11 crore in FY24, while revenue dropped 13.74% to ₹108.60 crore compared to ₹125.90 crore in the previous year. With a market cap of ₹9.19 billion and a P/E ratio of 32.28, Shree Ganesh Remedies has seen increased volatility amid earnings-driven selling pressure. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
